Journey Strategic Wealth’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Sell
1,094
-556
-34% -$136K 0.01% 670
2025
Q4
$418K Buy
1,650
+34
+2% +$8.54K 0.01% 363
2025
Q3
$400K Buy
1,616
+489
+43% +$117K 0.01% 357
2025
Q2
$271K Buy
1,127
+174
+18% +$40.5K 0.01% 477
2025
Q1
$216K Buy
+953
New +$210K 0.01% 447
2024
Q4
Sell
-925
Closed -$224K 550
2024
Q3
$224K Sell
925
-52
-5% -$12.2K 0.01% 436
2024
Q2
$214K Buy
+977
New +$212K 0.01% 348

Other funds holding STE

Journey Strategic Wealth's STE Position: Q1 2026 in Review

Journey Strategic Wealth reduced its Steris (STE) stake by 34% in Q1 2026, selling an estimated $136K and leaving 1,094 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #670.

Journey Strategic Wealth first reported a position in STE in Q2 2024 and has held it in 7 quarters since. The position peaked at $418K in Q4 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Journey Strategic Wealth held 1,094 shares of Steris worth $242K as of Q1 2026.
  • Journey Strategic Wealth sold 556 Steris shares in Q1 2026, an estimated $136K.
  • Steris made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #670 holding.
  • Journey Strategic Wealth first reported a position in Steris in Q2 2024 and has held it in 7 quarters since.
  • Journey Strategic Wealth's Steris position peaked at $418K in Q4 2025.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.